The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NSPR | -33.59% | -85.85% | -32.34% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +423% |
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
No news articles found for InspireMD.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.52M | 39.4% |
| Gross Profit | $864.00K | 108.7% |
| Gross Margin | 34.24% | 11.4% |
| Market Cap | $100.55M | 45.9% |
| Market Cap / Employee | $1.17M | 0.0% |
| Employees | 86 | 0.0% |
| Net Income | -$12,708.00K | -61.1% |
| EBITDA | -$12,923.00K | -54.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $63.40M | 300.8% |
| Accounts Receivable | $1.96M | 28.2% |
| Inventory | 3.6 | 47.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.37M | 247.1% |
| Short Term Debt | $1.01M | 84.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -71.65% | -15.5% |
| Return On Invested Capital | -71.34% | 16.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$8,962.00K | -46.4% |
| Operating Free Cash Flow | -$8,633.00K | -51.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.64 | 1.98 | 2.38 | 3.88 | 168.39% |
| Price to Sales | 18.34 | 19.14 | 16.39 | 22.76 | 19.76% |
| Price to Tangible Book Value | 1.64 | 1.98 | 2.38 | 3.88 | 168.39% |
| Enterprise Value to EBITDA | -10.36 | -9.74 | -7.73 | -9.06 | -15.99% |
| Return on Equity | -84.7% | -113.9% | -123.5% | -87.6% | 31.26% |
| Total Debt | $2.34M | $2.32M | $3.42M | $3.37M | 174.67% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
